Putative Probiotic Strains Isolated from Kefir Improve Gastrointestinal Health Parameters in Adults: a Randomized, Single-Blind, Placebo-Controlled Study
The dairy products remain as the largest reservoir for isolation of probiotic microorganisms. While probiotics have been immensely reported to exert various health benefits, it is also a common notion that these health potentials are strain and host dependent, leading to the need of more human evidence based on specific strains, health targets, and populations. This randomized, single-blind, and placebo-controlled human study aimed to evaluate the potential benefits of putative probiotic strains isolated from kefir on gastrointestinal parameters in fifty-six healthy adults. The consumption of AB-kefir (Bifidobacterium longum, Lactobacillus acidophilus, L. fermentum, L. helveticus, L. paracasei, L. rhamnosus, and Streptococcus thermophiles; total 10 log CFU/sachet) daily for 3 week reduced symptoms of abdominal pain, bloating (P = 0.014), and appetite (P = 0.041) in male subjects as compared to the control. Gut microbiota distribution profiles were shifted upon consumption of AB-kefir compared to baseline, where the abundance of bifidobacteria was increased in male subjects and maintained upon cessation of AB-kefir consumption. The consumption of AB-kefir also increased gastrointestinal abundance of total anaerobes (P = 0.038) and total bacterial (P = 0.049) in female subjects compared to the control after 3 weeks. Our results indicated that AB-kefir could potentially be developed as a natural strategy to improve gastrointestinal functions in adults.
KeywordsAB-kefir Abdominal bloating Abdominal pain Appetite Gut microbiota
The authors thank the funder for providing ideas in the stages of designing the experiments and reading the manuscript for intellectual content prior to submission as per decisions of authors.
Placebo and study product were produced by SYNBIO TECH INC.
MCW, WHL, JSL, and JJW conceived and designed the experiments and performed the study. AIZ, JSL, and MTL analyzed the data and wrote the manuscript.
This study was supported by the grant from The Southern Taiwan Science Park, Ministry of Science and Technology, Taiwan (Grant Number: 100CB03).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest
- 5.Hor YY, Lew LC, Lau ASY, Ong JS, Chuah LO, Lee YY, Choi SB, Rashid F, Wahid N, Sun Z, Kwok LY, Zhang H, Liong MT (2018) Probiotic Lactobacillus casei Zhang (LCZ) alleviates respiratory, gastrointestinal & RBC abnormality via immuno-modulatory, anti-inflammatory & anti-oxidative actions. J Funct Foods 44:235–245CrossRefGoogle Scholar
- 6.Lew LC, Hor YY, Khoo BY, Sasidharan S, Liong MT (2018) Lactobacillus plantarum DR7 reduces cholesterol via phosphorylation of AMPK that down-regulated the mRNA expression of HMGCR. Korean J Food Sci Animal Res 38:350–361Google Scholar
- 13.Feng P, Weagant SD, Grant MA, Burkhardt W, Shellfish M, Water B (2002) BAM: enumeration of Escherichia coli and the Coliform Bacteria. Bacteriological Analytical Manual 13Google Scholar
- 15.Cessna J (2017) Situation and outlook for the US dairy industry. Agricultural Outlook Forum2017.www.usda.gov/oce/forum/past_speeches/2017/2017_Speeches/Jerry_Cessna.pdf (accessed February 2019)
- 16.Chatellier V (2017) International European and French trade in dairy products: trends and competitive dynamics. https://hal.archives-ouvertes.fr/hal-01581619/document (accessed March 2019)
- 17.Di Cerbo A, Palmieri B (2015) The market of probiotics. Pak J Pharm Sci 28(6)Google Scholar
- 19.Ringel Y, Ringel-Kulka T, Maier D, Carroll I, Galanko JA, Leyer G, Palsson, O.S (2011) Clinical trial: probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders-a double-blind study. J Clin Gastroenterol 45(6):518.Google Scholar
- 24.Schmulson M, Adeyemo M, Gutiérrez-Reyes G, Charúa-Guindic L, Farfán-Labonne B, Ostrosky-Solis F, Díaz-Anzaldúa A, Medina L, Chang L (2010) Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Physiol Gastrointest 105(4):925CrossRefGoogle Scholar